KR840001518B1 - 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산(酸)의 제조방법 - Google Patents

3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산(酸)의 제조방법 Download PDF

Info

Publication number
KR840001518B1
KR840001518B1 KR1019810001169A KR810001169A KR840001518B1 KR 840001518 B1 KR840001518 B1 KR 840001518B1 KR 1019810001169 A KR1019810001169 A KR 1019810001169A KR 810001169 A KR810001169 A KR 810001169A KR 840001518 B1 KR840001518 B1 KR 840001518B1
Authority
KR
South Korea
Prior art keywords
compound
formula
tetramethyl
present
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019810001169A
Other languages
English (en)
Korean (ko)
Other versions
KR830005090A (ko
Inventor
이사오 야마쓰
오사무 다가야
유우이찌 이나이
고오이찌 스즈끼
고오이찌 아베
고오지 야마다
신야 아베
다께시 스즈끼
요시가즈 스즈끼
노조무 고야나기
Original Assignee
에-자 이 가부시끼가이샤
나이또오 유우지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에-자 이 가부시끼가이샤, 나이또오 유우지 filed Critical 에-자 이 가부시끼가이샤
Publication of KR830005090A publication Critical patent/KR830005090A/ko
Application granted granted Critical
Publication of KR840001518B1 publication Critical patent/KR840001518B1/ko
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019810001169A 1980-07-31 1981-04-07 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산(酸)의 제조방법 Expired KR840001518B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP55-104420 1980-07-31
JP10442080A JPS5731615A (en) 1980-07-31 1980-07-31 Remedy for skin disease with keratinization

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1019830005299A Division KR850000019B1 (ko) 1980-07-31 1983-11-08 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산(酸)의 제조방법

Publications (2)

Publication Number Publication Date
KR830005090A KR830005090A (ko) 1983-07-23
KR840001518B1 true KR840001518B1 (ko) 1984-09-29

Family

ID=14380194

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019810001169A Expired KR840001518B1 (ko) 1980-07-31 1981-04-07 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산(酸)의 제조방법
KR1019830005299A Expired KR850000019B1 (ko) 1980-07-31 1983-11-08 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산(酸)의 제조방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019830005299A Expired KR850000019B1 (ko) 1980-07-31 1983-11-08 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산(酸)의 제조방법

Country Status (4)

Country Link
US (1) US4346109A (https=)
JP (1) JPS5731615A (https=)
KR (2) KR840001518B1 (https=)
PH (1) PH15861A (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468458A (en) * 1980-01-12 1984-08-28 Eisai Co., Ltd. Two-functional-group-containing terpenoids, processes for the preparation of the same, and anti-ulcer agents containing the same
JPS56140949A (en) * 1980-04-07 1981-11-04 Eisai Co Ltd 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenic acid
JPS57106618A (en) * 1980-12-24 1982-07-02 Eisai Co Ltd Anticancer agent consisting of polyprenyl compound
JPS5815940A (ja) * 1981-07-23 1983-01-29 Eisai Co Ltd ポリプレニル系化合物およびその製造方法ならびにそれを含有する医薬
JPS5973516A (ja) * 1982-10-21 1984-04-25 Eisai Co Ltd 抗炎症剤
JPS59101448A (ja) * 1982-11-30 1984-06-12 Eisai Co Ltd ポリプレニルカルボン酸アミドおよびその製造方法ならびにそれを含有する医薬
FR2563431B1 (fr) * 1984-04-26 1987-03-06 Roussel Uclaf Nouvelles compositions cosmetiques renfermant des extraits lyses d'hafnia
GB2216003B (en) * 1988-02-18 1992-06-10 Toyama Chemical Co Ltd Hair restorer
US5175190A (en) * 1991-02-15 1992-12-29 The University Of British Columbia Medium chain fatty acids of C8-10 for the treatment of skin lesions
ES2343166T3 (es) * 2000-04-24 2010-07-26 Kowa Company, Ltd. Activadores para el receptor activado por proliferador de peroxisoma.
US20060094784A1 (en) * 2002-05-17 2006-05-04 Masataka Kagawa Tgf-alpha expression inhibitors
EP1547588B1 (en) * 2002-08-20 2013-12-11 Kowa Company, Ltd. Soft capsule preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966967A (en) * 1973-03-21 1976-06-29 The Regents Of The University Of California Compositions and methods of treating psoriasis with vinyligs of desmethyl retinoic acid
US3934028A (en) * 1974-04-22 1976-01-20 The Regents Of The University Of California Acne and psoriasis treatment with retinoic acid analogs
FR2329656A1 (fr) * 1975-10-30 1977-05-27 Hoffmann La Roche Procede de preparation de composes polyeniques, en particulier de carotenoides et de vitamine a
JPS52144614A (en) * 1976-05-27 1977-12-02 Eisai Co Ltd Polyprenyl carboxylic acid compounds and hypo-tensor containing same

Also Published As

Publication number Publication date
PH15861A (en) 1983-04-13
KR840004667A (ko) 1984-10-22
JPH0131484B2 (https=) 1989-06-26
US4346109A (en) 1982-08-24
JPS5731615A (en) 1982-02-20
KR830005090A (ko) 1983-07-23
KR850000019B1 (ko) 1985-02-11

Similar Documents

Publication Publication Date Title
CA2834341C (en) Oxidative retinal diseases
KR840001518B1 (ko) 3,7,11,15-테트라메틸-2,4,6,10,14-헥사데카펜타엔산(酸)의 제조방법
US4917829A (en) 3,7,11,15-Tetramethyl-2,4,6,10,14,-hexadecapentaendic acid
NZ247630A (en) Preparation comprising 9-cis or 13-cis-retinoic acid or acitretin and a vitamin d derivative
US4309407A (en) Alkenyl-substituted thienylalkanecarboxylic acids and derivatives thereof
EP0054732B1 (en) Conjugated polyprenylcarboxylic acids and their derivatives as well as pharmaceutical preparations containing these compounds
US5244917A (en) Substituted naphthofurans as anti-inflammatory agents
GB2073750A (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
US3626012A (en) Naphthyl acetaldehydes and derivatives thereof
US3641161A (en) Naphthyl alkanols
EP0059258B1 (en) Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases
US4835183A (en) Method of treating cancerous and precancerous conditions
US3674832A (en) Cyclopropane carboxylic acid derivatives
JP2963730B2 (ja) ポリスルフィド化合物及びこれを有効成分とする脂質過酸化抑制剤
US3792167A (en) Naphthyl alkanols and derivatives thereof,methods of use thereof,and processes for the preparation thereof
KR870000766B1 (ko) 폴리푸레닐계화합물의제조방법
JPS60104084A (ja) ４Ｈ‐ベンゾ〔４，５〕シクロヘプタ〔１，２‐ｂ〕チオフエン誘導体
EP0107188A1 (en) A pharmaceutical composition and the use thereof for the treatment of inflammation
US3821401A (en) Other publications
JPS6033373B2 (ja) １−ナフチル酢酸誘導体、その製造法ならびに１−ナフチル酢酸誘導体を含有する薬剤
US3272849A (en) 17-diethoxyethyl ethers of 3-alkoxy-1, 3, 5(10)-estratrienes
EP1119538B1 (en) Derivatives of phenantrene for medicinal use and a process for their preparation
US4483999A (en) Phenoxy alkanoic acid derivatives having the ability to lower the level of fatty substances in the blood
JPS5912118B2 (ja) 対称ヒドロキシ−チオアルカンの製造方法
CA3260833A1 (en) QUINONE-DERIVED COMPOUNDS AND THEIR USE AGAINST LEISHMANIA SPP.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19810407

PG1501 Laying open of application
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19830809

Patent event code: PE09021S01D

PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

Patent event date: 19840905

PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19850304

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19850313

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19850313

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19870828

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19871229

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19890817

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19900810

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19910814

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19920903

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19930331

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19940819

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 19950926

Start annual number: 12

End annual number: 12

PC1801 Expiration of term